Khosla Ventures SPAC cancels $2.8B Valo Health merger a day before shareholder vote
November 16, 2021 at 10:26 AM EST
Khosla and Boston-based Valo Health gave “current market conditions, particularly in the biotechnology area,” as the reason for calling off the deal, which was announced in June.